Sitagliptin tartrate hemihydrate is the tartrate salt and hemihydrate form of the active pharmaceutical ingredient sitagliptin. It is used as a compound in pharmaceutical manufacturing and as a research material.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 862156-93-2
Sitagliptin hydrochloride
pharmaceutical raw material
Sitagliptin
pharmaceutical raw material
Sitagliptin phosphate hydrate
pharmaceutical raw material
Sitagliptin phosphate
pharmaceutical raw material
Mirodenafil
pharmaceutical raw material
(3R)-1-azabicyclo(2.2.2)octan-3-yl (1R)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate butanedioate
pharmaceutical raw material
Ethyl eicosapentaenoate
pharmaceutical raw material
Vaprisol
pharmaceutical raw material
bis((3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one);bis((2R,3R)-2,3-dihydroxybutanedioic acid);hydrate
JEMGLDGZRMYQLM-RFGXFKENSA-N
C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N.C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.O